New insight into cell receptors opens the way for tailored cancer drugs

New Insight Into Cell Receptors Opens The Way For Tailored Cancer Drugs section is one about the Health and Medical Updates categories, posted over our writer Linda Norton upon February 11, 2019, those chapter maybe want to search just after these hastag cancer, cell, drugs, insight, opens, receptors, tailored. I am happy to glad you and providing that anothers chapter related health along with I am always updating the section everyday.

Cancer cell during cell division. Credit: National Institutes of Health

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer. This, according to researchers at Sweden’s Karolinska Institutet and Uppsala University, who have been collaborating with researchers in the U.K. and U.S. The results of their work, which concerns a group of G protein-coupled receptors called Class Frizzled (Class F), are published in the journal Nature Communications.

“Class F receptor dysfunction can be linked to different forms of cancer,” says Gunnar Schulte, study leader and professor at Karolinska Institutet’s Department of Physiology and Pharmacology. “We can now describe in molecular detail how the receptors are activated and try to find drugs that stop this activation to prevent tumour growth.”

The receptors on the cell membrane are activated by hormones or messenger molecules, which trigger a cascade of processes within. G protein-coupled receptors are among the largest protein families in the body and are an established drug target for a range of diseases. An important subgroup of G protein-coupled receptors are the so-called Class F receptors, but to date, they have not constituted a therapeutic target to any great extent.

In the present study, the researchers used newly developed methods to compare the mutation frequency of Class F receptors in tumours with the normal population. In linking cancer mutations to receptor function in this way, they may have found new opportunities for mechanism-based drug discovery. The study describes for the first time how regions of the Class F receptor act as a kind of switch for receptor activation, and how mutations in the receptor molecules can drive tumour development.

According to Professor Schulte, there are indications that other diseases, such as fibrosis, can also be linked to Class F receptor dysfunction. The researchers are currently working with the Swedish national research facility SciLifeLab to develop their ideas and explore potential new drugs.

“Drugs targeting receptors in this group have been unspecific,” Professor Schulte says. “We hope that it will now be possible to develop more effective drugs that can target individual receptors, drugs for cancers such as rectal, cervical and lung cancer.”

Receptor dynamics provide new potential for pharmaceutical developments

More information:
Shane C. Wright et al, A conserved molecular switch in Class F receptors regulates receptor activation and pathway selection, Nature Communications (2019). DOI: 10.1038/s41467-019-08630-2

Provided by
Karolinska Institutet

New insight into cell receptors opens the way for tailored cancer drugs (2019, February 11)
retrieved 11 February 2019

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

You maybe want to view another section health just as our similar blogpost or you probably want to check it on top of popular chapter, I'm always updating this health chapter everyday for clue as well as hint also trick to manage our health also living that healthy lifestyle. Those paragraph is posted with Linda Norton with this title New Insight Into Cell Receptors Opens The Way For Tailored Cancer Drugs.

Related posts of "New insight into cell receptors opens the way for tailored cancer drugs"

Physician burnout tied to ability to address social needs

(HealthDay)—Improving clinic capacity to respond to patients' social needs may reduce primary care physician burnout, according to a study published in the January-February issue of the Journal of the American Board of Family Medicine. Emilia De Marchis, M.D., from University of California San Francisco, and colleagues surveyed 1,298 family physicians in ambulatory primary care settings...

Aspartame and artificial sweeteners – helping or hindering weight loss?

With our appetite for low or zero sugar products increasing, artificial sweeteners are big business. Food or drinks containing artificial sweeteners are often marketed as a healthier option, and it's understandable why. Because artificial sweeteners are significantly sweeter than sugar, they can be used in very small amounts and contribute little to no calories. There...

New research findings could be key to improving outcomes for some brain cancers

IDH1-mutant glioma increases tumor cells' DNA damage response, reducing the efficacy of radiation treatment. Delivering a DNA damage repair inhibitor made the tumors sensitive to radiation treatment. Credit: Ella Marushchenko, art-director/illustrator and Alexander Tokarev, PhD from Ella Maru Studio Researchers from the University of Michigan Rogel Cancer Center have found that a genetic mutation seen...

Scientists identify a new ‘watchdog’ that controls intestinal bacteria

Annalaura Mastrangelo, David Sancho, Salvado Iborra, María Martínez-López, and Ruth Conde Garrosa. Credit: CNIC The immune response to our intestinal microbiota, the community of microorganisms that live in the human gut, ensures that these microorganisms remain in their proper place. When the intestinal immune barrier is damaged, the gut bacteria can spread and cause inflammation...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.